Cargando…
Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial
BACKGROUND: Smoking in patients with Schizophrenia is more common than in the general population. Varenicline, a partial agonist at α4β2 nicotinic acetylcholine receptors, is an effective smoking cessation pharmacotherapy in patients with Schizophrenia. However, its effects on the serum levels of an...
Autores principales: | Deng, Mengling, Yang, Zhi, Ni, Yanfei, Zhu, Lingli, Xu, Jiating, Zheng, Lifeng, Zhou, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235537/ https://www.ncbi.nlm.nih.gov/pubmed/37275966 http://dx.doi.org/10.3389/fpsyt.2023.1142419 |
Ejemplares similares
-
Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine
por: Ma, Jun, et al.
Publicado: (2021) -
Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021) -
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
por: Ahmed, Saeed, et al.
Publicado: (2018) -
Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022) -
Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)